A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
Clinical trial NCT05137262 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05137262
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2028-08-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.